A carregar...
PD-L1 assessment in urothelial carcinoma: a practical approach
Five programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors are currently approved for treatment of locally advanced or metastatic urothelial carcinoma of the bladder and the upper urinary tract. Due to restrictions by the FDA and EMA first-line treatment with Atezolizumab and Pembro...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944605/ https://ncbi.nlm.nih.gov/pubmed/31930091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.10.24 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|